DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of SelectQuote

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against SelectQuote, Inc. due to allegations of violations of federal securities laws related to misleading statements and illegal kickbacks [4][6][7] Group 1: Allegations Against SelectQuote - The complaint alleges that SelectQuote directed Medicare beneficiaries to plans that compensated the company best, regardless of quality [6] - SelectQuote is accused of failing to provide unbiased comparisons for Medicare Advantage insurance plans [6] - The company allegedly received illegal kickbacks from health insurers to steer beneficiaries towards certain plans, limiting enrollment in competitors' offerings [6] - SelectQuote's actions reportedly made it vulnerable to regulatory and legal sanctions, including violations of the False Claims Act [6] - The U.S. Department of Justice filed a complaint stating that SelectQuote received "tens of millions of dollars" in illegal kickbacks from 2016 to 2021 [7] Group 2: Impact on Stock and Legal Proceedings - Following the DOJ's allegations, SelectQuote's stock price fell by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025, with unusually high trading volume [7] - Investors who suffered losses are encouraged to contact Faruqi & Faruqi to discuss their legal rights and options [4][9] - There is an October 10, 2025 deadline for investors to seek the role of lead plaintiff in the federal securities class action against SelectQuote [4]